"We provide a range of specialized Clinical Trials for adult patients in the Sacramento area. Our focus is on spreading the word about our various volunteer opportunities in our clinical trials and research studies."

During the past decade, Northern California Research conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 49 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 28 clinical trials were completed. i.e. 147.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern California Research" #1 sponsor was "Pfizer" with 5 trials, followed by "Purdue Pharma LP" with 5 trials sponsored, "Jazz Pharmaceuticals" with 4 trials sponsored, "Repros Therapeutics Inc." with 4 trials sponsored and "Urovant Sciences GmbH" with 4 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern California Research" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Medpace, Inc." with 2 trials as a collaborator, "Paidion Research, Inc." with 2 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator and "Beaufort" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Northern California Research" are "Overactive Bladder" (5 trials), "Fibromyalgia" (4 trials), "Obesity" (4 trials), "Secondary Hypogonadism" (4 trials) and "Diabetes Mellitus, Type 2" (3 trials). Many other conditions were trialed in "Northern California Research" in a lesser frequency.

Most popular intervention types in "Northern California Research" are "Drug" (77 trials), "Biological" (12 trials), "Other" (9 trials), "Behavioral" (3 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "placebo" (7 trials), "Androxal" (4 trials), "Vibegron" (3 trials) and "Xyrem®" (3 trials). Other intervention names were less common.

The vast majority of trials in "Northern California Research" are 75 trials for "All" genders, 12 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Northern California Research". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 76 completed trials in Northern California Research, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Northern California Research, 1 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 5 trials that are defined as “Not Applicable".